GPGA
CSTL icon

Grandeur Peak Global Advisors’s Castle Biosciences CSTL Stock Holding History

Grandeur Peak Global Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-544,723
Closed -$24.4M – 116
2022
Q1 		$24.4M Buy
544,723
+206,266
+61% +$8.52M 1.16% 22
2021
Q4 		$14.5M Buy
338,457
+107,161
+46% +$5.6M 0.66% 29
2021
Q3 		$15.4M Buy
231,296
+16,078
+7% +$1.13M 0.73% 27
2021
Q2 		$15.8M Buy
215,218
+175,879
+447% +$11.6M 0.75% 27
2021
Q1 		$2.69M Buy
39,339
+30,520
+346% +$2.29M 0.15% 75
2020
Q4 		$592K Hold
8,819
– – 0.03% 101
2020
Q3 		$454K Sell
8,819
-2,081
-19% -$92.6K 0.03% 99
2020
Q2 		$411K Sell
10,900
-4,075
-27% -$139K 0.03% 100
2020
Q1 		$446K Sell
14,975
-17,250
-54% -$520K 0.05% 99
2019
Q4 		$1.11M Sell
32,225
-47,150
-59% -$1.15M 0.1% 76
2019
Q3 		$1.44M Buy
+79,375
New +$1.76M 0.16% 72

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Grandeur Peak Global Advisors's CSTL Position: Q2 2022 in Review

Grandeur Peak Global Advisors sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 544,723 shares — an estimated $24.4M sold.

Grandeur Peak Global Advisors first reported a position in CSTL in Q3 2019 and held it in 11 quarters. The position peaked at $24.4M in Q1 2022. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Grandeur Peak Global Advisors reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 544,723 Castle Biosciences shares in Q2 2022, an estimated $24.4M.
  • Grandeur Peak Global Advisors first reported a position in Castle Biosciences in Q3 2019 and held it in 11 quarters.
  • Grandeur Peak Global Advisors's Castle Biosciences position peaked at $24.4M in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Grandeur Peak Global Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.